Raising funds in life sciences doesn’t always follow a traditional path, and increasingly, companies are exploring alternative routes to get there. Join us for a ‘lunch & learn’ with the CEO of Galenband, who led an oversubscribed, crowdfunding round, raising over €1.75M from 160+ investors.

In this session, we’ll explore:

• Why companies choose crowdfunding and alternative funding routes
• What it takes to run a successful campaign
• How it compares to traditional VC and angel investment
• The role of storytelling, visibility, and community in driving momentum

This will be a practical, honest conversation designed for founders navigating the realities of fundraising, whether you’re actively raising or planning ahead.

Light lunch provided.